RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Farin Kamangar to Retrospective Studies

This is a "connection" page, showing publications Farin Kamangar has written about Retrospective Studies.
Connection Strength

0.529
  1. Amini A, Najafi A, Ahmadi A, Mojtahedzadeh M, Karimpour-Razkenari E, Sharifnia H, Shahsavar Mistani S, Kamangar F. Predictors of Mortality among COVID-19 Patients Admitted to Intensive Care Units: A Single-Center Study in Tehran, Iran. Arch Iran Med. 2022 10 01; 25(10):676-681.
    View in: PubMed
    Score: 0.146
  2. Percy-Laurry A, Altekruse SF, Hossain MB, O'Keefe AM, Johnson NJ, Kamangar F. Association Between Socioeconomic Status and Tumor Grade Among Black Men with Prostate Cancer. J Natl Med Assoc. 2018 Feb; 110(1):53-57.
    View in: PubMed
    Score: 0.101
  3. Ashktorab H, Pizuorno A, Adeleye F, Laiyemo A, Dalivand MM, Aduli F, Sherif ZA, Oskrochi G, Angesom K, Oppong-Twene P, Challa SR, Okorie N, Moon ES, Romos E, Jones-Wonni B, Kone AM, Rankine S, Thrift C, Scholes D, Ekwunazu C, Banson A, Mitchell B, Maskalo G, Ross J, Curtis J, Kim R, Gilliard C, Ahuja G, Mathew J, Gavin W, Kara A, Hache-Marliere M, Palaiodimos L, Mani VR, Kalabin A, Gayam VR, Garlapati PR, Miller J, Chirumamilla LG, Jackson F, Carethers JM, Kamangar F, Brim H. Symptomatic, clinical and biomarker associations for mortality in hospitalized COVID-19 patients enriched for African Americans. BMC Infect Dis. 2022 Jun 17; 22(1):552.
    View in: PubMed
    Score: 0.036
  4. Karimi A, Mohebbi E, Mckay-Chopin S, Rashidian H, Hadji M, Peyghambari V, Marzban M, Naghibzadeh-Tahami A, Gholipour M, Kamangar F, Tommasino M, Gheit T, Zendehdel K. Human Papillomavirus and Risk of Head and Neck Squamous Cell Carcinoma in Iran. Microbiol Spectr. 2022 08 31; 10(4):e0011722.
    View in: PubMed
    Score: 0.036
  5. Kashanian SM, Holtzman NG, Patzke CL, Cornu J, Duffy A, Koka M, Niyongere S, Duong VH, Baer MR, Apata J, Kamangar F, Emadi A. Venous thromboembolism incidence and risk factors in adults with acute lymphoblastic leukemia treated with and without pegylated E. coli asparaginase-containing regimens. Cancer Chemother Pharmacol. 2021 06; 87(6):817-826.
    View in: PubMed
    Score: 0.033
  6. Chen YC, Thio CL, Kamangar F, Cox AL, Wiberg KJ. Evolving trends in the prevalence of hepatitis C virus antibody positivity among HIV-infected men in a community-based primary care setting. J Viral Hepat. 2020 11; 27(11):1202-1213.
    View in: PubMed
    Score: 0.031
  7. Chen YC, Thio CL, Cox AL, Ruhs S, Kamangar F, Wiberg KJ. Trends in hepatitis C treatment initiation among HIV/hepatitis C virus-coinfected men engaged in primary care in a multisite community health centre in Maryland: a retrospective cohort study. BMJ Open. 2019 03 30; 9(3):e027411.
    View in: PubMed
    Score: 0.029
  8. Maqsood H, Patel K, Ferdosi H, Sill AM, Wu B, Buddensick T, Sautter A, Shaukat H, Sulkowski G, Narducci DM, Siddique M, Kamangar F, Kowdley GC, Cunningham SC. Age-related differences pre-, intra-, and postcholecystectomy: A retrospective cohort study of 6,868 patients. Int J Surg. 2017 Mar; 39:119-126.
    View in: PubMed
    Score: 0.025
  9. Oliver N, Short B, Thein M, Duong VH, Tidwell ML, Sausville EA, Baer MR, Kamangar F, Emadi A. Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation. Leuk Lymphoma. 2015 Jul; 56(7):2082-6.
    View in: PubMed
    Score: 0.021
  10. Wu B, Buddensick TJ, Ferdosi H, Narducci DM, Sautter A, Setiawan L, Shaukat H, Siddique M, Sulkowski GN, Kamangar F, Kowdley GC, Cunningham SC. Predicting gangrenous cholecystitis. HPB (Oxford). 2014 Sep; 16(9):801-6.
    View in: PubMed
    Score: 0.020
  11. Freedman ND, Murray LJ, Kamangar F, Abnet CC, Cook MB, Nyr?n O, Ye W, Wu AH, Bernstein L, Brown LM, Ward MH, Pandeya N, Green AC, Casson AG, Giffen C, Risch HA, Gammon MD, Chow WH, Vaughan TL, Corley DA, Whiteman DC. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON Consortium. Gut. 2011 Aug; 60(8):1029-37.
    View in: PubMed
    Score: 0.016
  12. DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD. Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg. 2007 May; 245(5):755-62.
    View in: PubMed
    Score: 0.013
  13. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Iacobuzio-Donahue C, Ashfaq R, Kern SE, Maitra A, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Montgomery E, Schulick RD. MKK4 status predicts survival after resection of gastric adenocarcinoma. Arch Surg. 2006 Nov; 141(11):1095-9; discussion 1100.
    View in: PubMed
    Score: 0.012
  14. Cunningham SC, Kamangar F, Kim MP, Hammoud S, Haque R, Maitra A, Montgomery E, Heitmiller RE, Choti MA, Lillemoe KD, Cameron JL, Yeo CJ, Schulick RD. Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution. J Gastrointest Surg. 2005 May-Jun; 9(5):718-25.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support